(Q33389722)

26 July 2017

title

Malignant epithelioid mesothelioma: anti-mesothelial marker expression correlates with histological pattern (English)

1 reference

26 July 2017

Attanoos RL

1

1 reference

26 July 2017

Webb R

series ordinal

2

1 reference

26 July 2017

Dojcinov SD

series ordinal

3

1 reference

26 July 2017

Gibbs AR

series ordinal

4

1 reference

26 July 2017

language of work or name

1 reference

1 December 2001

1 reference

26 July 2017

1 reference

26 July 2017

volume

39

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

584-588

1 reference

Pathology of malignant mesothelioma

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01295.X

Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01295.X

Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01295.X

Morphological and immunophenotypic variations in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01295.X

CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01295.X

CD44 is the principal cell surface receptor for hyaluronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01295.X

The immunohistochemical diagnosis of epithelial mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01295.X

10.1046/J.1365-2559.2001.01295.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference